Daniel D Shapiro - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Daniel D Shapiro

Showing results (61-70 of 69) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 69 results.

European Urology|March 1, 2026

KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic ModelChad Tang, Aaron Seo, Alexander D Sherry, et al.

Research Square|November 28, 2024

Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinomaSangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.

Nature Communications|February 21, 2025

Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trialSangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.

Urologic Oncology|November 5, 2024

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meetingStephanie A Berg, Salvatore La Rosa, Tian Zhang, et al.

Cancers|December 10, 2021

Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal StudiesDaniel D Shapiro, Melinda Soeung, Luigi Perelli, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023

SMARCB1 regulates the hypoxic stress response in sickle cell traitMelinda Soeung, Luigi Perelli, Ziheng Chen, et al.

European Urology|January 24, 2025

A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer TypesAxel Bex, Michael Jewett, Bryan Lewis, et al.

Urologic Oncology|August 17, 2025

Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think TankDaniel D Shapiro, Edwin Jason Abel, Laurence Albiges, et al.

Cancer Cell|May 4, 2020

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary CarcinomaPavlos Msaouel, Gabriel G Malouf, Xiaoping Su, et al.

Pageof 7

Search research articles

Showing results (61-70 of 69) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 69 results.

European Urology|March 1, 2026

Research Square|November 28, 2024

Nature Communications|February 21, 2025

Urologic Oncology|November 5, 2024

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meetingStephanie A Berg, Salvatore La Rosa, Tian Zhang, et al.

Cancers|December 10, 2021

Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023

SMARCB1 regulates the hypoxic stress response in sickle cell traitMelinda Soeung, Luigi Perelli, Ziheng Chen, et al.

European Urology|January 24, 2025

A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer TypesAxel Bex, Michael Jewett, Bryan Lewis, et al.

Urologic Oncology|August 17, 2025

Cancer Cell|May 4, 2020

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary CarcinomaPavlos Msaouel, Gabriel G Malouf, Xiaoping Su, et al.

Pageof 7